Previous Close | 0.1500 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 12.50 |
Expire Date | 2024-05-17 |
Day's Range | 0.1500 - 0.1500 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Q3 2024 Avid Bioservices Inc Earnings Call
Explore the detailed financial performance and strategic responses of Avid Bioservices in the face of declining revenues and margins.
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion Program with Grand Opening of Cell and Gene Therapy Manufacturing Facility in January 2024 -- -- Completed Convertible Debt Offering Subsequent to Quarter End, Extending Debt Maturity to 2029 -- TUSTIN, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics